Literature DB >> 19411182

Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature.

Bing-Heng Yang1, Ming-Yieh Peng, Shu-Jin Hou, Jun-Ren Sun, Shih-Yi Lee, Jang-Jih Lu.   

Abstract

Kodamaea (Pichia) ohmeri was formerly considered a contaminant, but is now known to be a significant human pathogen that has been shown to cause fungemia, endocarditis, funguria, and peritonitis in immunocompromised patients. We report a case of fungemia caused by K. ohmeri in a 71-year-old man with cellulitis. The patient was sent to the emergency room due to leg edema, fever, and change of consciousness. During hospitalization, a series of examinations including blood cultures were performed. On hospital day 8, blood culture yielded a yeast colony. Fluconazole was given empirically, but had no effect. The pathogen was identified as K. ohmeri by Vitek YBC card, API 20C, sequencing of the 18S rRNA gene, and the D1/D2 domains of the 26S rRNA gene and the internally transcribed spacer (ITS) regions. Antifungal susceptibility testing was performed with the ATB-Fungus system, and a high minimum inhibitory concentration (level up to 64 mg/l) for fluconazole was found. Fluconazole was replaced with amphotericin B deoxylate, and the fever and cellulitis inflammation gradually subsided. The patient was discharged in a stable condition. This is the first case of K. ohmeri fungemia in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411182     DOI: 10.1016/j.ijid.2009.02.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  11 in total

1.  Photodynamic inactivation of biofilms formed by Candida spp., Trichosporon mucoides, and Kodamaea ohmeri by cationic nanoemulsion of zinc 2,9,16,23-tetrakis(phenylthio)-29H, 31H-phthalocyanine (ZnPc).

Authors:  J C Junqueira; A O C Jorge; J O Barbosa; R D Rossoni; S F G Vilela; A C B P Costa; F L Primo; J M Gonçalves; A C Tedesco; J M A H Suleiman
Journal:  Lasers Med Sci       Date:  2012-01-26       Impact factor: 3.161

2.  Use of antifungal agents in pediatric and adult high-risk areas.

Authors:  E Ramírez; J García-Rodríguez; A M Borobia; J M Ortega; S Lei; A Barrios-Fernández; M Sánchez; A J Carcas; A Herrero; J M de la Puente; J Frías
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-01       Impact factor: 3.267

Review 3.  Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature.

Authors:  Hamid Shaaban; Hoo Feng Choo; Jack Boghossian; George Perez
Journal:  Mycopathologia       Date:  2010-05-07       Impact factor: 2.574

4.  Kodameae ohmeri - An Emerging Yeast: Two Cases and Literature Review.

Authors:  Debadulal Biswal; Manisa Sahu; Asmita Mahajan; Suresh H Advani; Suresh Shah
Journal:  J Clin Diagn Res       Date:  2015-03-01

5.  Central line associated bloodstream infection caused by Kodamaea ohmeri in a young child.

Authors:  Amier Haidar; Farhana Khaja; Brian Simms; Amr Issam Elgehiny; Tracy Omoegbele; Nikita Khetan
Journal:  Germs       Date:  2021-12-29

6.  Molecular identification and antifungal susceptibility pattern of Candida species isolated from HIV infected Patients with candisiasis.

Authors:  Sony Paul; Iyanar Kannan
Journal:  Curr Med Mycol       Date:  2019-03

7.  Fungemia due to Kodamaea ohmeri in a young infant and review of the literature.

Authors:  Rosalba Vivas; Claudia Beltran; Maria Isabel Munera; Monica Trujillo; Andrea Restrepo; Carlos Garcés
Journal:  Med Mycol Case Rep       Date:  2016-06-20

8.  Kodamaea ohmeri fungemia in severe burn: Case study and literature review.

Authors:  Ayaka Tashiro; Takahito Nei; Ryoji Sugimoto; Akiko Watanabe; Jun Hagiwara; Toru Takiguchi; Hiroyuki Yokota; Katsuhiko Kamei
Journal:  Med Mycol Case Rep       Date:  2018-07-20

9.  Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study.

Authors:  Menglan Zhou; Shuying Yu; Timothy Kudinha; Meng Xiao; He Wang; Yingchun Xu; Hongmei Zhao
Journal:  Infect Drug Resist       Date:  2019-06-12       Impact factor: 4.003

10.  Assaying the effect of yeasts on growth of fungi associated with disease.

Authors:  Enikő Horváth; Matthias Sipiczki; Hajnalka Csoma; Ida Miklós
Journal:  BMC Microbiol       Date:  2020-10-21       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.